院外心脏骤停中紧急医疗服务目击病例的发病率与结局全球差异:系统综述与Meta分析
本系统综述与Meta分析检索4个电子数据库1990年至2021年4月5日研究,纳入33个国家66篇文献共133,981例EMS目击并治疗的OHCA患者。汇总发病率为4.1/10万人年(95%CI 3.5-4.7),各大洲间相差近4倍。汇总生存出院或30天生存率总体20%(95%CI 18%-22%;I2=98%),初始可电击心律43%(95%CI 37%-49%;I2=94%),初始不可电击心律6%(95%CI 5%-8%;I2=79%)。Meta回归显示仅地区和病因与生存显著相关,欧洲与澳大拉西亚生存率显著高于北美。作者结论为全球发病率与生存结局存在显著差异,需进一步研究理解造成差异的因素。
要点
- EMS目击OHCA汇总发病率为4.1/10万人年(95%CI 3.5-4.7),各大洲间差异近4倍。
- 汇总生存出院或30天生存率总体20%(95%CI 18%-22%;I2=98%)。
- 初始可电击心律生存率43%(95%CI 37%-49%;I2=94%),初始不可电击心律6%(95%CI 5%-8%;I2=79%)。
- Meta回归中仅地区与病因与生存显著相关:与北美相比,欧洲生存率14% vs 26%(p=0.04),澳大拉西亚14% vs 31%(p<0.001)。
- 66篇文献中仅12篇(18%)为低偏倚风险,总体证据以观察性研究为主。
适用人群与场景
- 紧急医疗服务(EMS)目击的院外心脏骤停(OHCA)患者,由EMS治疗,来自33个国家。
- 纳入标准:报告足够数据以计算主要结局(生存出院或30天生存)的研究。
研究设计与关键结果
- 研究类型:系统综述与Meta分析,检索4个电子数据库1990年至2021年4月5日发表的研究。
- 纳入66篇文献,共133,981例EMS目击并治疗的OHCA患者,覆盖33个国家;除1项研究外均为观察性研究,仅12项研究(18%)被判定为低偏倚风险。
- 汇总发病率:4.1/10万人年(95%CI 3.5-4.7),各大洲间相差近4倍。
- 主要结局:汇总生存出院或30天生存率总体20%(95%CI 18%-22%;I2=98%)。
- 按初始心律分层:初始可电击心律生存率43%(95%CI 37%-49%;I2=94%);初始不可电击心律生存率6%(95%CI 5%-8%;I2=79%)。
- Meta回归:仅地区和病因与生存显著相关;与北美研究相比,欧洲研究汇总生存率14% vs 26%(p=0.04),澳大拉西亚研究14% vs 31%(p<0.001)。
证据类型、等级与局限
- 证据类型:系统综述与Meta分析,纳入研究以观察性研究为主。
- 研究质量:采用Joanna Briggs Institute批判性评估工具评价,仅12项研究(18%)为低偏倚风险。
- 异质性:总体生存率I2=98%,初始可电击心律I2=94%,初始不可电击心律I2=79%。
- 局限:原文报告需进一步研究以理解造成全球差异的因素。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM OF THE REVIEW: To examine global variation in the incidence and outcomes of emergency medical services (EMS) witnessed out-of-hospital cardiac arrest (OHCA).
DATA SOURCES: We systematically reviewed four electronic databases for studies between 1990 and 5th April 2021 reporting EMS-witnessed OHCA populations. Studies were included if they reported sufficient data to calculate the primary outcome of survival to hospital discharge or 30-day survival. Random-effects models were used to pool incidence and survival outcomes, and meta-regression was used to examine sources of heterogeneity. Study quality was appraised using the Joanna Briggs Institute critical appraisal tools.
RESULTS: The search returned 1178 non-duplicate titles of which 66 articles comprising 133,981 EMS-witnessed patients treated by EMS across 33 countries were included. All but one study was observational and only 12 studies (18%) were deemed to be at low risk of bias. The pooled incidence of EMS-treated cases was 4.1 per 100,000 person-years (95% CI: 3.5, 4.7), varying almost 4-fold across continents. The pooled proportion of survivors to hospital discharge or 30-days was 20% overall (95% CI: 18%, 22%; I2 = 98%), 43% (95% CI: 37%, 49%; I2 = 94%) for initial shockable rhythms and 6% (95% CI: 5%, 8%; I2 = 79%) for initial non-shockable rhythms. In the meta-regression analysis, only region and aetiology were significantly associated with survival. When compared to studies from North America, pooled survival was significantly higher in studies from Europe (14% vs. 26%; p = 0.04) and Australasia (14% vs. 31%, p < 0.001).
CONCLUSION: We identified significant global variation in the incidence and survival outcome of EMS-witnessed OHCA. Further research is needed to understand the factors contributing to these variations.
参考来源
- Gowens P, Smith K, Clegg G, et al. Global variation in the incidence and outcome of emergency medical services witnessed out-of-hospital cardiac arrest: A systematic review and meta-analysis. Resuscitation. 2022. PMID: 35367317. doi:10.1016/j.resuscitation.2022.03.026
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。